Effect of topical application of quercetin-3-O-(2″-gallate)-α-l-rhamnopyranoside on atopic dermatitis in NC/Nga mice

J Dermatol Sci. 2015 Mar;77(3):166-72. doi: 10.1016/j.jdermsci.2014.12.005. Epub 2015 Jan 3.

Abstract

Background: Quercetin-3-O-(2″-gallate)-α-l-rhamnopyranoside (QGR) is a new quercetin derivative which is isolated from the leaves of Acer ginnala Maxim, a native plant of Korea. Quercetin has several biological effects including antioxidative, anti-inflammatory, and anti-allergic effects. However, the topical effect of QGR on atopic dermatitis (AD) like skin lesion in NC/Nga mice has not been studied.

Objective: To evaluate the anti-inflammatory and anti-allergic effect of QGR in a murine model of atopic dermatitis.

Methods: We measured inducible nitric oxide synthase (iNOS) and cyclooxygenase -2(COX-2) level in RAW264.7 cell with QGR treatment. And after induction of AD like skin lesions with Dermatophagoides farina (Df) ointment, mice were treated with QGR and control drugs. Clinical scores, interleukin (IL) 4, 5, and 13, serum IgE, eosinophil levels, iNOS and COX-2 level were evaluated.

Results: Results show that mRNA level of iNOS and COX-2 in vitro were decreased after QGR treatment. Topical QGR markedly decreased the iNOS and COX-2 mRNA expressions in the skin. QGR also significantly suppressed the increase in the level of total plasma IgE and eosinophils. In addition, topical application of QGR down-regulated the expressions of the cytokines, IL-4,5 and 13, which were induced by Df ointment stimulation.

Conclusions: In the present study, we showed that topical application of QGR ameliorated Df-induced AD-like inflammatory responses in NC/Nga mice. These results demonstrate that QGR might be beneficial in the treatment of AD.

Keywords: Atopic dermatitis; Cytokine; Mouse model; Quercetin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Cells, Cultured
  • Cyclooxygenase 2 / drug effects
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism*
  • Dermatitis, Atopic / blood
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / enzymology
  • Eosinophils*
  • Female
  • Immunoglobulin E / blood
  • Interleukin-13 / blood
  • Interleukin-4 / blood
  • Interleukin-5 / blood
  • Leukocyte Count
  • Macrophages / drug effects
  • Macrophages / enzymology
  • Mice
  • Nitric Oxide Synthase Type II / drug effects
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism*
  • Peptidoglycan / pharmacology
  • Quercetin / administration & dosage
  • Quercetin / analogs & derivatives*
  • Quercetin / therapeutic use
  • RNA, Messenger / metabolism

Substances

  • Interleukin-13
  • Interleukin-5
  • Peptidoglycan
  • RNA, Messenger
  • quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside
  • Interleukin-4
  • Immunoglobulin E
  • Quercetin
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2